Total Funding
22
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer.
James Snyder: Co-Founder
Dennis C. Liotta: Co-FounderPast Role: Emory University, Pharmaceutical Researcher
About the Company
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection.
Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
Women Founded
